Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-02-19$1.86/sh−11$20→ 240,671 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.